Back to top
more

Ecolab (ECL)

(Delayed Data from NYSE)

$244.57 USD

244.57
1,399,786

-1.16 (-0.47%)

Updated Nov 1, 2024 04:00 PM ET

After-Market: $244.55 -0.02 (-0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 43% (142 out of 250)

Industry: Chemical - Specialty

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Amerigo (ARREF) Affirms 2024 Guidance Despite Heavy Rains

by Zacks Equity Research

Amerigo (ARREF) anticipates heavy rains in Chile to impact its copper output by 1 million pounds.

Trinseo (TSE) Launches PMMA Depolymerization Facility in Italy

by Zacks Equity Research

Trinseo (TSE) opens a PMMA depolymerization facility in Italy, advancing sustainable recycling technology.

Element Solutions (ESI) Rallies 15% in 6 Months: Here's Why

by Zacks Equity Research

Element Solutions' (ESI) performance in the past six months is driven by strong performance and raised financial guidance for 2024.

BASF (BASFY) & Vattenfall Partner Vestas for Wind Turbines

by Zacks Equity Research

Vattenfall, BASF (BASFY) and Vestas intend to swiftly expand wind projects and decarbonize the European energy market.

Air Products (APD) Commences Expansion at Missouri Facility

by Zacks Equity Research

The new manufacturing facility by Air Products (APD) is set to start production by the end of 2025, with the addition of 30 full-time workers.

Intuitive Surgical (ISRG) Hits 52-Week High: What's Aiding It?

by Zacks Equity Research

Investors are optimistic about Intuitive Surgical's (ISRG) strength in robotics.

Ekso Bionics' (EKSO) New Partnership to Aid Its Ekso Devices

by Zacks Equity Research

Ekso Bionics (EKSO) announces a research partnership with Shepherd Center to create training and research programs for the Ekso devices.

DuPont (DD) Acquires Donatelle Plastics, Boosts Medical Portfolio

by Zacks Equity Research

DuPont (DD) announces an agreement to acquire Donatelle Plastics, enhancing its expertise in medical devices and expanding its healthcare solutions portfolio.

Westlake (WLK) Adds New Colors to Mid-America Shutters Line

by Zacks Equity Research

The four new colors by Westlake (WLK) complement current siding color trends and expand the Mid-America shutters line.

Here's Why You Should Add Ecolab (ECL) to Your Portfolio Now

by Zacks Equity Research

Ecolab's (ECL) focus on research and development raises optimism about the stock

GE HealthCare's (GEHC) New Tie-Up to Boost CVD Workflow

by Zacks Equity Research

GE HealthCare's (GEHC) latest collaboration is likely to enable clinicians to perform complex cardiology interventions with a high level of precision and improved image quality.

Sheraz Mian headshot

Top Stock Reports for Chevron, Amgen & Philip Morris

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including Chevron Corporation (CVX), Amgen Inc. (AMGN) and Philip Morris International Inc. (PM), as well as two micro-cap stocks Hurco Companies, Inc. (HURC) and Perma-Pipe International Holdings, Inc. (PPIH).

Agnico Eagle (AEM) Bumps Up Stake in Maple Gold Mines to 19.9%

by Zacks Equity Research

Agnico Eagle (AEM) raises its stake in Maple Gold Mines Ltd to 19.9%. It enters into a deal under which Maple will obtain a 100% interest in the Douay and Joutel Gold Projects.

Mosaic's (MOS) April and May Sales Volume and Revenues Down

by Zacks Equity Research

Mosaic (MOS) posts significant declines in sales volume and revenues across potash, phosphate and Mosaic Fertilizantes in April and May 2024.

Fission Uranium (FCUUF) Agrees to be Acquired by Paladin Energy

by Zacks Equity Research

Fission Uranium (FCUUF) is set to be acquired by Paladin Energy. This deal will create a leading uranium producer with a robust portfolio of exploration, development and production assets.

Should You Invest in the iShares U.S. Basic Materials ETF (IYM)?

by Zacks Equity Research

Sector ETF report for IYM

Air Liquide (AIQUY) to Invest Up to $850M in Low-Carbon Oxygen

by Zacks Equity Research

The agreement allows Air Liquide (AIQUY) to capitalize on its existing pipeline infrastructure to promote the development of low-carbon hydrogen.

BASF (BASFY) and Enerflex Collaborate for CCUS Applications

by Zacks Equity Research

Per the deal, Enerflex's engineering, manufacturing and integration experience in gas processing and compression systems will be combined with BASF's (BASFY) OASE blue technology for CO2 capture.

GE HealthCare (GEHC) Boosts Interventional Radiology Capabilities

by Zacks Equity Research

GE HealthCare's (GEHC) latest successful first installation and clinical cases using the OmnifyXR are likely to improve clinical and operational outcomes for both patients and clinicians.

Accuray (ARAY), TrueNorth Unite to Aid Radiation Departments

by Zacks Equity Research

Accuray (ARAY) announces an agreement with TrueNorth to provide radiation oncology departments with third-party support designed to improve their department's capabilities.

BASF (BASFY)-Encina Announce Long-Term Recycled Benzene Deal

by Zacks Equity Research

BASF (BASFY) and Encina ink a long-term agreement to supply chemically recycled circular benzene, advancing sustainable sourcing and circular economy goals.

Bunge Global (BG) to Sell Its 50% Stake in BP Bunge Bioenergia

by Zacks Equity Research

Bunge Global (BG) to focus on core businesses with the sale of its shares in the BP Bunge Bioenergia joint venture.

B2Gold (BTG) Sells 10% Stake in Calibre Mining for C$139M

by Zacks Equity Research

B2Gold (BTG) sells 79 million common shares of Calibre Mining as part of its capital allocation strategy.

Air Liquide (AIQUY) & Dunkerque Project Gets EU's Support

by Zacks Equity Research

The D'Artagnan project will involve an Air Liquide (AIQUY) pipeline carrying CO2 from capture sites, as well as a terminal in the port of Dunkirk for liquefying and loading CO2 onto ships.

McKesson (MCK) Reaches 52-Week High: What's Aiding the Stock?

by Zacks Equity Research

Investors are optimistic about McKesson's (MCK) strength in its Biologics business.